| Wendi A Quentin, PT | |
|
4448 W Loomis Rd, #205, Greenfield, WI 53220-4800 | |
| (414) 281-5151 | |
| Not Available |
| Full Name | Wendi A Quentin |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 31 Years |
| Location | 4448 W Loomis Rd, Greenfield, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083749147 | NPI | - | NPPES |
| 40372800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 4541 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakeshore Medical Clinic Llc | 7719890730 | 300 |
News Archive
Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
Scientists and engineers will face a host of obstacles over the next decade in providing clean water to millions of people caught up in a water shortage crisis, a panel of scientists and engineers said today at a briefing at the Broadcast Center of the National Press Building on the Final Report on the American Chemical Society's Global Challenges/Chemistry Solutions.
More than 220,000 American adults die suddenly of cardiac causes – a phenomenon called sudden cardiac death. Some sources put it as closer to 400,000. Both inexplicable and distressing, this has been the subject of a new study published in the Journal of the American College of Cardiology and presented at the American Heart Association's scientific session.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients.
› Verified 7 days ago
| Provider Name | Aurora Medical Group, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
Scientists and engineers will face a host of obstacles over the next decade in providing clean water to millions of people caught up in a water shortage crisis, a panel of scientists and engineers said today at a briefing at the Broadcast Center of the National Press Building on the Final Report on the American Chemical Society's Global Challenges/Chemistry Solutions.
More than 220,000 American adults die suddenly of cardiac causes – a phenomenon called sudden cardiac death. Some sources put it as closer to 400,000. Both inexplicable and distressing, this has been the subject of a new study published in the Journal of the American College of Cardiology and presented at the American Heart Association's scientific session.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients.
› Verified 7 days ago
| Provider Name | Lakeshore Medical Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003861188 PECOS PAC ID: 7719890730 Enrollment ID: O20031106000481 |
News Archive
Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
Scientists and engineers will face a host of obstacles over the next decade in providing clean water to millions of people caught up in a water shortage crisis, a panel of scientists and engineers said today at a briefing at the Broadcast Center of the National Press Building on the Final Report on the American Chemical Society's Global Challenges/Chemistry Solutions.
More than 220,000 American adults die suddenly of cardiac causes – a phenomenon called sudden cardiac death. Some sources put it as closer to 400,000. Both inexplicable and distressing, this has been the subject of a new study published in the Journal of the American College of Cardiology and presented at the American Heart Association's scientific session.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients.
› Verified 7 days ago
| Provider Name | Aurora Health Care Metro Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861447179 PECOS PAC ID: 8628986536 Enrollment ID: O20040114000498 |
News Archive
Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
Scientists and engineers will face a host of obstacles over the next decade in providing clean water to millions of people caught up in a water shortage crisis, a panel of scientists and engineers said today at a briefing at the Broadcast Center of the National Press Building on the Final Report on the American Chemical Society's Global Challenges/Chemistry Solutions.
More than 220,000 American adults die suddenly of cardiac causes – a phenomenon called sudden cardiac death. Some sources put it as closer to 400,000. Both inexplicable and distressing, this has been the subject of a new study published in the Journal of the American College of Cardiology and presented at the American Heart Association's scientific session.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients.
› Verified 7 days ago
| Provider Name | Aurora Advanced Healthcare Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
Scientists and engineers will face a host of obstacles over the next decade in providing clean water to millions of people caught up in a water shortage crisis, a panel of scientists and engineers said today at a briefing at the Broadcast Center of the National Press Building on the Final Report on the American Chemical Society's Global Challenges/Chemistry Solutions.
More than 220,000 American adults die suddenly of cardiac causes – a phenomenon called sudden cardiac death. Some sources put it as closer to 400,000. Both inexplicable and distressing, this has been the subject of a new study published in the Journal of the American College of Cardiology and presented at the American Heart Association's scientific session.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendi A Quentin, PT 4448 W Loomis Rd, #205, Greenfield, WI 53220-4800 Ph: (414) 281-5151 | Wendi A Quentin, PT 4448 W Loomis Rd, #205, Greenfield, WI 53220-4800 Ph: (414) 281-5151 |
News Archive
Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
Scientists and engineers will face a host of obstacles over the next decade in providing clean water to millions of people caught up in a water shortage crisis, a panel of scientists and engineers said today at a briefing at the Broadcast Center of the National Press Building on the Final Report on the American Chemical Society's Global Challenges/Chemistry Solutions.
More than 220,000 American adults die suddenly of cardiac causes – a phenomenon called sudden cardiac death. Some sources put it as closer to 400,000. Both inexplicable and distressing, this has been the subject of a new study published in the Journal of the American College of Cardiology and presented at the American Heart Association's scientific session.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients.
› Verified 7 days ago
Mckenzie Fauth, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5700 W Layton Ave, Greenfield, WI 53220 Phone: 414-281-7200 | |
William Quebrado, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4861 S 27th St, Greenfield, WI 53221 Phone: 414-325-3325 Fax: 414-325-3334 | |
Elizabeth A Majszak, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4131 W Loomis Rd, Greenfield, WI 53221 Phone: 414-281-5151 | |
Dr. Dennis Chester Sobush, PT, MA, DPT, CCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3920 S 120th St, Greenfield, WI 53228 Phone: 414-546-2667 | |
Ann Cates, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4848 S 76th St, Greenfield, WI 53220 Phone: 414-282-2899 Fax: 414-282-2988 | |
Theresa Sebestyen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5020 S 110th St, Greenfield, WI 53228 Phone: 414-425-1970 | |
John K Pulkrabek, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 7517 W Coldspring Rd, Greenfield, WI 53220 Phone: 414-327-6603 |